6ix — Find Your Next Investment

Discover investor relations events, company profiles, and investment opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Latest Press Releases

Time	Headline
1m ago	DBGI Announces the Launch of its Vanderbilt University Apparel Program
1m ago	Elektros Inc. Unveils Breakthrough EV Charging Patent Positioned to Transform Multi-Billion Dollar Infrastructure Market
2m ago	Masco Corporation Announces Leadership Changes
2m ago	Moleculin Announces Abstract Accepted for Poster Presentation at the 2026 ASCO Annual Meeting
3m ago	Laser Photonics Reports Fourth Quarter 2025 Financial Results

About

Moleculin Biotech Inc (NASDAQ:MBRX) — investor relations, events, news, and company updates on 6ix.

Latest News

Moleculin Announces Abstract Accepted for Poster Presentation at the 2026 ASCO Annual Meeting

Moleculin Releases Next CEO Corner Segment Highlighting Annamycin’s Non-Cardiotoxic Profile

Moleculin Hits 45 Subject Enrollment Milestone, Triggering Final Countdown to Mid-2026 MIRACLE Trial Data Readout

Moleculin Reports Full Year 2025 Financial Results and Confirms Highly Anticipated 45-Patient Interim Data Unblinding in Pivotal MIRACLE Trial On Track for Mid-2026

Moleculin to Present at 38th Annual ROTH Conference

Financials

Revenue

$0

Market Cap

$13.61 M

EPS

-28.42

Community Chat

Ask AI

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren